Vibrio vulnificus septicemia in a patient with liver cirrhosis.
Chan
T Y
TY
Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories.
Chow
D P
DP
Ng
K C
KC
Pang
K W
KW
McBride
G A
GA
D000818:Animals; D016470:Bacteremia / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D003386:Brachyura / Q000382:microbiology*; D002442:Ceftazidime / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008875:Middle Aged; D010125:Ostreidae / Q000382:microbiology*; D017747:Seafood / Q000382:microbiology*; D014735:Vibrio Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology
D002939:Ciprofloxacin; D002442:Ceftazidime